LUCEMYRA (Lofexadine) ASAM 2020 Guide Recommend Outpatient Management Opioid Withdrawal Symptoms
LUCEMYRA the first & only non-opioid, non-addictive treatment for relief of multiple symptoms of opioid withdrawal in adults. ASAM 2020 Guide Recommenation: “Lofexidine should therefore be the preferred choice for withdrawal management in an Outpatient-setting, where monitoring of blood pressure and management of hypotension is more difficult.”.
Beyond OUD/addiction withdrawal, there is opportunity to support Trauma, Injury, Burn, & Surgery Patients who are treated with opioid analgesic therapy. Continued opioid use almost inevitably leads to physical Opioid dependence. Patients who continue opioid use are on the path to physical opioid dependence and may experience Opioid Withdrawal Syndrome (OWS).
--Anyone using opioid pain medication can develop a physical need for opioids in as early as 5 days.
--After ONE MONTH of use, 30% of patients still use opioids ONE YEAR later.
--Avoidance of withdrawal symptoms is a driver of continued opioid use. —LUCEMYRA, indicated for mitigation of opioid withdrawal symptoms to facilitate abrupt opioid discontinuation in adults, can help you to help Physically Dependent Patients, who present Opioid Withdrawal Symptoms, to discontinue Opioid therapy.
